International Clinical Trial: A phase 2 study to evaluate the efficacy of zabalafin hydrogel in treating Molluscum Contagiosum in participants of 6 months to 13 years of age

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000303347) titled 'A phase 2 study to evaluate the efficacy of zabalafin hydrogel in treating Molluscum Contagiosum in participants of 6 months to 13 years of age' on March 10.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used) Assignment: Parallel

Primary Sponsor: Alphyn Biologics, Inc.

Condition: Molluscum Contagiosum Skin infection Molluscum Contagiosum Skin infection Skin - Dermatological conditions Inflammatory and Immune System - Other inflammatory or immune system disorders

Intervention: Zabalafin Hydrogel 9.5%, A thin layer of the Z...